NYSE:AREHealth Care REITs
Alexandria Real Estate Equities (ARE) Puts Precision Medicine In Focus Following A Fair Value Test
Alexandria Real Estate Equities (ARE) is back in focus after announcing that the Multi-Modal Assessment and Phenotyping in Depression initiative with the Foundation for the National Institutes of Health has completed its critical design phase.
See our latest analysis for Alexandria Real Estate Equities.
At a share price of $53.77, Alexandria Real Estate Equities has seen a 90 day share price return of 32.73%, while the 1 year total shareholder return is down 26.89%. This indicates that...